title: [Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
authors.forename: A
authors.initials: A
authors.lastname: Waage
authors.forename: J
authors.initials: J
authors.lastname: Hammerstrøm
authors.forename: B
authors.initials: B
authors.lastname: Lødemel
authors.forename: J E
authors.initials: JE
authors.lastname: Hoff
authors.forename: J
authors.initials: J
authors.lastname: Langtind
mesh_terms: D000368:Aged; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
chemical_list: D003561:Cytarabine
vernacular_title: Myelodysplastisk syndrom og myelogen leukemi. Behandlet med lavdose cytarabin.